Meta Biomed Co. Ltd Asset Resilience Ratio
Meta Biomed Co. Ltd asset resilience ratio. Meta Biomed Co. Ltd (059210) has an Asset Resilience Ratio of 11.86% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 059210 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Meta Biomed Co. Ltd (2011–2024)
Asset resilience ratio of Meta Biomed Co. Ltd from 2011 to 2024. This chart shows how Meta Biomed Co. Ltd's Asset Resilience Ratio has changed over time. Read Meta Biomed Co. Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Meta Biomed Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Meta Biomed Co. Ltd (059210) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩21.36 Billion | 11.86% |
| Total Liquid Assets | ₩21.36 Billion | 11.86% |
Asset Resilience Insights
- Moderate Liquidity: Meta Biomed Co. Ltd has 11.86% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Meta Biomed Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Meta Biomed Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Value Added Technology Co. Ltd
KQ:043150 |
Healthcare Equipment & Supplies | 3.34% |
|
Elbit Med Tech
TA:EMTC |
Healthcare Equipment & Supplies | 7.83% |
|
InBody Co.Ltd
KQ:041830 |
Healthcare Equipment & Supplies | 20.98% |
|
INFINITT Healthcare Co. Ltd
KQ:071200 |
Healthcare Equipment & Supplies | 61.76% |
|
i-SENS Inc
KQ:099190 |
Healthcare Equipment & Supplies | 8.59% |
|
Sewoon Medical Co. Ltd
KQ:100700 |
Healthcare Equipment & Supplies | 11.84% |
|
MEDIANA Co.Ltd
KQ:041920 |
Healthcare Equipment & Supplies | 39.47% |
|
CU Medical Systems Inc
KQ:115480 |
Healthcare Equipment & Supplies | 6.84% |
Meta Biomed Co. Ltd Asset Resilience Ratio by Year (2011–2024)
Meta Biomed Co. Ltd asset resilience ratio by year from 2011 to 2024. The table below shows the annual Asset Resilience Ratio data for Meta Biomed Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 30.63% | ₩54.30 Billion ≈ $36.80 Million |
₩177.30 Billion ≈ $120.15 Million |
+17.71pp |
| 2023-12-31 | 12.92% | ₩16.81 Billion ≈ $11.39 Million |
₩130.12 Billion ≈ $88.18 Million |
-2.89pp |
| 2022-12-31 | 15.81% | ₩19.14 Billion ≈ $12.97 Million |
₩121.07 Billion ≈ $82.05 Million |
+0.38pp |
| 2021-12-31 | 15.43% | ₩15.92 Billion ≈ $10.79 Million |
₩103.13 Billion ≈ $69.89 Million |
-4.08pp |
| 2020-12-31 | 19.51% | ₩21.04 Billion ≈ $14.26 Million |
₩107.86 Billion ≈ $73.09 Million |
+11.67pp |
| 2019-12-31 | 7.84% | ₩8.10 Billion ≈ $5.49 Million |
₩103.29 Billion ≈ $70.00 Million |
+1.69pp |
| 2018-12-31 | 6.15% | ₩6.01 Billion ≈ $4.07 Million |
₩97.69 Billion ≈ $66.21 Million |
+0.99pp |
| 2017-12-31 | 5.17% | ₩6.18 Billion ≈ $4.19 Million |
₩119.66 Billion ≈ $81.10 Million |
-2.03pp |
| 2016-12-31 | 7.19% | ₩8.64 Billion ≈ $5.85 Million |
₩120.08 Billion ≈ $81.37 Million |
+4.19pp |
| 2015-12-31 | 3.01% | ₩3.42 Billion ≈ $2.32 Million |
₩113.78 Billion ≈ $77.11 Million |
-2.08pp |
| 2014-12-31 | 5.09% | ₩5.85 Billion ≈ $3.97 Million |
₩115.06 Billion ≈ $77.97 Million |
-3.82pp |
| 2013-12-31 | 8.91% | ₩10.40 Billion ≈ $7.05 Million |
₩116.79 Billion ≈ $79.15 Million |
+8.63pp |
| 2012-12-31 | 0.28% | ₩288.31 Million ≈ $195.38K |
₩103.43 Billion ≈ $70.09 Million |
-5.03pp |
| 2011-12-31 | 5.31% | ₩2.86 Billion ≈ $1.94 Million |
₩53.89 Billion ≈ $36.52 Million |
-- |
About Meta Biomed Co. Ltd
Meta Biomed Co., Ltd. engages in the research and development, production, and marketing of dental and surgical materials in South Korea and internationally. The company's dental products include endodontics, endodontic materials, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics; bone product… Read more